Kepos Capital’s DexCom DXCM Stock Holding History

Kepos Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-48,532	Closed	-$1.45M	–	337
2019 Q1	$1.45M	Hold	48,532	–	–	0.11%	186
2018 Q4	$1.45M	Buy	+48,532	New	+$1.54M	0.11%	173

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kepos Capital's DXCM Position: Q2 2019 in Review

Kepos Capital sold out of DexCom (DXCM) in Q2 2019, closing a stake of 48,532 shares — an estimated $1.45M sold.

Kepos Capital first reported a position in DXCM in Q4 2018 and held it in 2 quarters. The position peaked at $1.45M in Q4 2018. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

Kepos Capital reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
Kepos Capital sold 48,532 DexCom shares in Q2 2019, an estimated $1.45M.
Kepos Capital first reported a position in DexCom in Q4 2018 and held it in 2 quarters.
Kepos Capital's DexCom position peaked at $1.45M in Q4 2018.
418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on Kepos Capital's 13F filing for Q2 2019, filed 13 Aug 2019.